Immediate COVID-19 Vaccine & Therapeutic Fill/Finish Production Availability Announced by Argonaut Manufacturing Services

By |March 23rd, 2020|Drug Product Manufacturing, Press Release|

Advanced Facility Readies to Combat COVID-19 (Carlsbad, CA) March 23, 2020 – Argonaut Manufacturing Services announced today it has immediate availability for aseptic drug product manufacturing fill/finish service. Argonaut will provide services for [...]

Need for Pharmaceutical and Diagnostics Surge Capacity Revealed by the Coronavirus Outbreak

By |March 10th, 2020|Drug Product Manufacturing, Manufacturing, Supply Chain|

The global COVID-19 outbreak has served as an important lesson for companies worldwide on the importance of supply chain integrity. Factory shutdowns across China are wreaking havoc on unprepared companies in every industry, leaving organizations scr [...]

Open Biopharma and Argonaut Manufacturing Services selected to host BIO International Ecosystem Tour in North County, San Diego

By |March 3rd, 2020|Drug Product Manufacturing, Press Release|

CARLSBAD, CA, Mar. 3, 2020 Open Biopharma Research and Training Institute and Argonaut Manufacturing Services announced today their selection as a Biotech Ecosystem Tour for the 2020 BIO International Convention. Ecosystem Tours are competitively cho [...]

Argonaut Manufacturing Services and Particle Measuring Systems Partnering for Top Tier Results

By |February 25th, 2020|Drug Product Manufacturing, Press Release, Uncategorized|

Partnership leverages their individual strengths to achieve high quality, reliable drug product manufacturing. February 25, 2020 – Argonaut Manufacturing Services, a contract development and manufacturing organization (CDMO) for biopharmaceuticals, a [...]

Argonaut Manufacturing Services announces launch of aseptic drug product manufacturing services

By |January 7th, 2020|Drug Product Manufacturing, Press Release|

New introduction supports industry shortage of high-yield filling service providers CARLSBAD, CA – Argonaut Manufacturing Services, a premier contract development and manufacturing organization (CDMO) for biopharma, has announced the recent launch of [...]

How to Minimize API Loss: A Case Study in Aseptic Fill/Finish

By |November 21st, 2019|Drug Product Manufacturing|

With API (active pharmaceutical ingredient) values continuing to climb as production scales conversely drop, it is time to rethink our aseptic filling processes to minimize API loss. The rise in biologics and personalized medicine has led to APIs wit [...]

Make Versus Buy: Evaluating your Aseptic Fill/Finish Manufacturing Strategy

By |October 9th, 2019|Drug Product Manufacturing, Useful Tips|

Every biopharma company is eventually faced with the “make versus buy” decision – should they fill/finish their drug product in-house or outsource? Complicating things further, a third option also exists to outsource a portion while retaining some i [...]

New manufacturing strategies for the precision medicine future

By |July 11th, 2019|Drug Product Manufacturing|

Blockbuster drugs and one-size-fits-all treatments now share portfolio space with highly targeted therapies for smaller patient populations. This new era is an opportunity for savvy companies to create greater value, both for patients and themselves. [...]

Selecting the Right CDMO Partner – Three Keys to Success

By |May 16th, 2019|Drug Product Manufacturing|

Outsourcing pharmaceutical manufacturing is becoming essential to remain competitive in the industry. The rise of small-batch personalized medicines and “virtual companies” are key drivers to retain flexible, external manufacturing capabilities. With [...]